how glp 1 drugs work Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review Weight loss drugs – hope

Demand for such drugs is likely to continue to be strong in the future due to rising rates of obesity and interlinked chronic diseases

Understanding where things are heading provides additional context for the Toujeo versus GLP-1 discussion

According to the Semaglutide Treatment Effect in People with Obesity (STEP) program studies, people with overweight or obesity (without T2DM) who received semaglutide 2.4 mg and underwent lifestyle interventions experienced an average weight reduction of 14.7- 17.4% [116]

They are rarely given a structured framework for exercise and protein in the same conversation

Cost and Insurance Coverage Considerations GLP-1 medication costs vary substantially, and insurance coverage often determines which options are realistically accessible